Search

Your search keyword '"Martelotto, Luciano G."' showing total 322 results

Search Constraints

Start Over You searched for: Author "Martelotto, Luciano G." Remove constraint Author: "Martelotto, Luciano G."
322 results on '"Martelotto, Luciano G."'

Search Results

1. Systematic benchmarking of single-cell ATAC-sequencing protocols

2. snPATHO-seq, a versatile FFPE single-nucleus RNA sequencing method to unlock pathology archives

3. FixNCut: single-cell genomics through reversible tissue fixation and dissociation

4. Ligand-dependent hedgehog signaling maintains an undifferentiated, malignant osteosarcoma phenotype

6. Fancm has dual roles in the limiting of meiotic crossovers and germ cell maintenance in mammals

9. A Comparative Analysis of Imaging-Based Spatial Transcriptomics Platforms

10. snPATHO-seq: unlocking the pathology archives

11. Antigen-driven EGR2 expression is required for exhausted CD8+ T cell stability and maintenance

12. Same-Cell Co-Occurrence of RAS Hotspot and BRAF V600E Mutations in Treatment-Naive Colorectal Cancer

13. Reprogramming roadmap reveals route to human induced trophoblast stem cells

14. Hotspot activating PRKD1 somatic mutations in polymorphous low-grade adenocarcinomas of the salivary glands

15. Systematic benchmarking of single-cell ATAC-sequencing protocols

16. FixNCut: Single-cell genomics through reversible tissue fixation and dissociation

20. Supplementary Table from Epigenetic Activation of Plasmacytoid DCs Drives IFNAR-Dependent Therapeutic Differentiation of AML

21. Data from γδ T Cells in Merkel Cell Carcinomas Have a Proinflammatory Profile Prognostic of Patient Survival

22. Data from Epigenetic Activation of Plasmacytoid DCs Drives IFNAR-Dependent Therapeutic Differentiation of AML

23. Supplementary Table S1 from Combined BRAF, MEK, and CDK4/6 Inhibition Depletes Intratumoral Immune-Potentiating Myeloid Populations in Melanoma

24. Supplementary Figure from Epigenetic Activation of Plasmacytoid DCs Drives IFNAR-Dependent Therapeutic Differentiation of AML

25. Data from Combined BRAF, MEK, and CDK4/6 Inhibition Depletes Intratumoral Immune-Potentiating Myeloid Populations in Melanoma

26. Supplementary Data from γδ T Cells in Merkel Cell Carcinomas Have a Proinflammatory Profile Prognostic of Patient Survival

27. Supplementary Tables from γδ T Cells in Merkel Cell Carcinomas Have a Proinflammatory Profile Prognostic of Patient Survival

28. Supplementary Figures from γδ T Cells in Merkel Cell Carcinomas Have a Proinflammatory Profile Prognostic of Patient Survival

29. Supplementary Figures from Combined BRAF, MEK, and CDK4/6 Inhibition Depletes Intratumoral Immune-Potentiating Myeloid Populations in Melanoma

30. Data from CDK4/6 Inhibition Promotes Antitumor Immunity through the Induction of T-cell Memory

31. TableS1.xlsx from CDK4/6 Inhibition Promotes Antitumor Immunity through the Induction of T-cell Memory

32. Supplementary Figures from CDK4/6 Inhibition Promotes Antitumor Immunity through the Induction of T-cell Memory

33. Supplementary Tables S1-S3 from The Genomic Landscape of Male Breast Cancers

34. Supplementary methods and Figure Legends from Diverse BRCA1 and BRCA2 Reversion Mutations in Circulating Cell-Free DNA of Therapy-Resistant Breast or Ovarian Cancer

35. Supplementary Tables S11 and S12 from The Genomic Landscape of Male Breast Cancers

36. Supplementary Table S1 from Diverse BRCA1 and BRCA2 Reversion Mutations in Circulating Cell-Free DNA of Therapy-Resistant Breast or Ovarian Cancer

37. Supplementary Figure S1 from Diverse BRCA1 and BRCA2 Reversion Mutations in Circulating Cell-Free DNA of Therapy-Resistant Breast or Ovarian Cancer

38. Supplementary Figures S6-S10 from The Genomic Landscape of Male Breast Cancers

39. Supplementary Methods from The Genomic Landscape of Male Breast Cancers

40. Supplementary Figures S4 and S5 from The Genomic Landscape of Male Breast Cancers

41. Supplementary Figures and Tables from IDH2 Mutations Define a Unique Subtype of Breast Cancer with Altered Nuclear Polarity

42. Data from IDH2 Mutations Define a Unique Subtype of Breast Cancer with Altered Nuclear Polarity

43. Supplementary Figure Legends from IDH2 Mutations Define a Unique Subtype of Breast Cancer with Altered Nuclear Polarity

44. Supplementary Materials and Methods from IDH2 Mutations Define a Unique Subtype of Breast Cancer with Altered Nuclear Polarity

45. Supplementary Methods, Tables 1-3, Figures 1-4 from Hedgehog Overexpression Is Associated with Stromal Interactions and Predicts for Poor Outcome in Breast Cancer

46. Data from Hedgehog Overexpression Is Associated with Stromal Interactions and Predicts for Poor Outcome in Breast Cancer

47. Genetic events in the progression of adenoid cystic carcinoma of the breast to high-grade triple-negative breast cancer

49. Targeting enhancer switching overcomes non-genetic drug resistance in acute myeloid leukaemia

Catalog

Books, media, physical & digital resources